[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Covid-19 Impact on Atopic Eczema Treatment Market, Global Research Reports 2020-2021

June 2020 | 93 pages | ID: CB5D91B25773EN
QYResearch

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report covers market size and forecasts of Atopic Eczema Treatment, including the following market information:
  • Global Atopic Eczema Treatment Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
  • Global Atopic Eczema Treatment Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
  • Global Atopic Eczema Treatment Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
  • Global Atopic Eczema Treatment Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Key market players

Major competitors identified in this market include Leo Pharma, Velite Pharmaceutical, Pfizer, Anacor Pharmaceutical, Regeneron Pharmaceuticals, Sanofi, etc.

Based on the Region:
  • Asia-Pacific (China, Japan, South Korea, India and ASEAN)
  • North America (US and Canada)
  • Europe (Germany, France, UK and Italy)
  • Rest of World (Latin America, Middle East & Africa)
Based on the Type:
  • Oral
  • Topical
  • Parenteral
Based on the Application:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
  1.4.1 Research Process
  1.4.2 Data Triangulation
  1.4.3 Research Approach
  1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
  1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
  1.5.2 Covid-19 Impact: Commodity Prices Indices
  1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Atopic Eczema Treatment Industry
1.7 COVID-19 Impact: Atopic Eczema Treatment Market Trends

2 GLOBAL ATOPIC ECZEMA TREATMENT QUARTERLY MARKET SIZE ANALYSIS

2.1 Atopic Eczema Treatment Business Impact Assessment - COVID-19
  2.1.1 Global Atopic Eczema Treatment Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Atopic Eczema Treatment Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
  2.3.1 Drivers
  2.3.2 Restraints
  2.3.3 Opportunities
  2.3.4 Challenges

3 QUARTERLY COMPETITIVE ASSESSMENT, 2020

3.1 By Players, Global Atopic Eczema Treatment Quarterly Market Size, 2019 VS 2020
3.2 By Players, Atopic Eczema Treatment Headquarters and Area Served
3.3 Date of Key Players Enter into Atopic Eczema Treatment Market
3.4 Key Players Atopic Eczema Treatment Product Offered
3.5 Mergers & Acquisitions, Expansion Plans

4 IMPACT OF COVID-19 ON ATOPIC ECZEMA TREATMENT SEGMENTS, BY TYPE

4.1 Introduction
  1.4.1 Oral
  1.4.2 Topical
  1.4.3 Parenteral
4.2 By Type, Global Atopic Eczema Treatment Market Size, 2019-2021

5 IMPACT OF COVID-19 ON ATOPIC ECZEMA TREATMENT SEGMENTS, BY APPLICATION

5.1 Overview
  5.5.1 Hospital Pharmacies
  5.5.2 Retail Pharmacies
  5.5.3 Online Pharmacies
5.2 By Application, Global Atopic Eczema Treatment Market Size, 2019-2021
  5.2.1 By Application, Global Atopic Eczema Treatment Market Size by Application, 2019-2021

6 GEOGRAPHIC ANALYSIS

6.1 Introduction
6.2 North America
  6.2.1 Macroeconomic Indicators of US
  6.2.2 US
  6.2.3 Canada
6.3 Europe
  6.3.1 Macroeconomic Indicators of Europe
  6.3.2 Germany
  6.3.3 France
  6.3.4 UK
  6.3.5 Italy
6.4 Asia-Pacific
  6.4.1 Macroeconomic Indicators of Asia-Pacific
  6.4.2 China
  6.4.3 Japan
  6.4.4 South Korea
  6.4.5 India
  6.4.6 ASEAN
6.5 Rest of World
  6.5.1 Latin America
  6.5.2 Middle East and Africa

7 COMPANY PROFILES

7.1 Leo Pharma
  7.1.1 Leo Pharma Business Overview
  7.1.2 Leo Pharma Atopic Eczema Treatment Quarterly Revenue, 2020
  7.1.3 Leo Pharma Atopic Eczema Treatment Product Introduction
  7.1.4 Leo Pharma Response to COVID-19 and Related Developments
7.2 Velite Pharmaceutical
  7.2.1 Velite Pharmaceutical Business Overview
  7.2.2 Velite Pharmaceutical Atopic Eczema Treatment Quarterly Revenue, 2020
  7.2.3 Velite Pharmaceutical Atopic Eczema Treatment Product Introduction
  7.2.4 Velite Pharmaceutical Response to COVID-19 and Related Developments
7.3 Pfizer
  7.3.1 Pfizer Business Overview
  7.3.2 Pfizer Atopic Eczema Treatment Quarterly Revenue, 2020
  7.3.3 Pfizer Atopic Eczema Treatment Product Introduction
  7.3.4 Pfizer Response to COVID-19 and Related Developments
7.4 Anacor Pharmaceutical
  7.4.1 Anacor Pharmaceutical Business Overview
  7.4.2 Anacor Pharmaceutical Atopic Eczema Treatment Quarterly Revenue, 2020
  7.4.3 Anacor Pharmaceutical Atopic Eczema Treatment Product Introduction
  7.4.4 Anacor Pharmaceutical Response to COVID-19 and Related Developments
7.5 Regeneron Pharmaceuticals
  7.5.1 Regeneron Pharmaceuticals Business Overview
  7.5.2 Regeneron Pharmaceuticals Atopic Eczema Treatment Quarterly Revenue, 2020
  7.5.3 Regeneron Pharmaceuticals Atopic Eczema Treatment Product Introduction
  7.5.4 Regeneron Pharmaceuticals Response to COVID-19 and Related Developments
7.6 Sanofi
  7.6.1 Sanofi Business Overview
  7.6.2 Sanofi Atopic Eczema Treatment Quarterly Revenue, 2020
  7.6.3 Sanofi Atopic Eczema Treatment Product Introduction
  7.6.4 Sanofi Response to COVID-19 and Related Developments

8 KEY FINDINGS

9 APPENDIX

9.1 About US
9.2 Disclaimer
LIST OF TABLES

Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Atopic Eczema Treatment Assessment
Table 9. COVID-19 Impact: Atopic Eczema Treatment Market Trends
Table 10. COVID-19 Impact Global Atopic Eczema Treatment Market Size
Table 11. Global Atopic Eczema Treatment Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Atopic Eczema Treatment Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Atopic Eczema Treatment Market Growth Drivers
Table 14. Global Atopic Eczema Treatment Market Restraints
Table 15. Global Atopic Eczema Treatment Market Opportunities
Table 16. Global Atopic Eczema Treatment Market Challenges
Table 17. By Players, Atopic Eczema Treatment Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Atopic Eczema Treatment Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Atopic Eczema Treatment Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Atopic Eczema Treatment Market
Table 21. Key Players Atopic Eczema Treatment Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Atopic Eczema Treatment Market Size 2019-2021, (US$ Million)
Table 24. Global Atopic Eczema Treatment Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Atopic Eczema Treatment Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Atopic Eczema Treatment Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Atopic Eczema Treatment Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Atopic Eczema Treatment Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Atopic Eczema Treatment Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Atopic Eczema Treatment Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Atopic Eczema Treatment Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Atopic Eczema Treatment Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Atopic Eczema Treatment Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Atopic Eczema Treatment Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Atopic Eczema Treatment Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Atopic Eczema Treatment Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Atopic Eczema Treatment Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Atopic Eczema Treatment Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Atopic Eczema Treatment Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Atopic Eczema Treatment Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Atopic Eczema Treatment Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Atopic Eczema Treatment Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Atopic Eczema Treatment Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Atopic Eczema Treatment Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Atopic Eczema Treatment Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Atopic Eczema Treatment Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Atopic Eczema Treatment Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Atopic Eczema Treatment Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Atopic Eczema Treatment Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Atopic Eczema Treatment Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Atopic Eczema Treatment Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Atopic Eczema Treatment Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Atopic Eczema Treatment Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Atopic Eczema Treatment Market Size, 2019-2021 (US$ Million)
Table 57. Leo Pharma Business Overview
Table 58. Leo Pharma Atopic Eczema Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Leo Pharma Atopic Eczema Treatment Product
Table 60. Leo Pharma Response to COVID-19 and Related Developments
Table 61. Velite Pharmaceutical Business Overview
Table 62. Velite Pharmaceutical Atopic Eczema Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Velite Pharmaceutical Atopic Eczema Treatment Product
Table 64. Velite Pharmaceutical Response to COVID-19 and Related Developments
Table 65. Pfizer Business Overview
Table 66. Pfizer Atopic Eczema Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Pfizer Atopic Eczema Treatment Product
Table 68. Pfizer Response to COVID-19 and Related Developments
Table 69. Anacor Pharmaceutical Business Overview
Table 70. Anacor Pharmaceutical Atopic Eczema Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Anacor Pharmaceutical Atopic Eczema Treatment Product
Table 72. Anacor Pharmaceutical Response to COVID-19 and Related Developments
Table 73. Regeneron Pharmaceuticals Business Overview
Table 74. Regeneron Pharmaceuticals Atopic Eczema Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Regeneron Pharmaceuticals Atopic Eczema Treatment Product
Table 76. Regeneron Pharmaceuticals Response to COVID-19 and Related Developments
Table 77. Sanofi Business Overview
Table 78. Sanofi Atopic Eczema Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Sanofi Atopic Eczema Treatment Product
Table 80. Sanofi Response to COVID-19 and Related Developments

LIST OF FIGURES

Figure 1. Atopic Eczema Treatment Product Picture
Figure 2. Atopic Eczema Treatment Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Atopic Eczema Treatment Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Atopic Eczema Treatment Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Atopic Eczema Treatment Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Atopic Eczema Treatment Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Atopic Eczema Treatment Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Atopic Eczema Treatment Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Atopic Eczema Treatment Market Size Market Share, 2019-2021


More Publications